Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.colsurfb.2009.06.009
Title: Controlled release of dual drugs from emulsion electrospun nanofibrous mats
Authors: Yan, S.
Xiaoqiang, L.
Shuiping, L.
Xiumei, M.
Ramakrishna, S. 
Keywords: Control release
Emulsion electrospinning
Nanofibers
PLLACL
Issue Date: 15-Oct-2009
Citation: Yan, S., Xiaoqiang, L., Shuiping, L., Xiumei, M., Ramakrishna, S. (2009-10-15). Controlled release of dual drugs from emulsion electrospun nanofibrous mats. Colloids and Surfaces B: Biointerfaces 73 (2) : 376-381. ScholarBank@NUS Repository. https://doi.org/10.1016/j.colsurfb.2009.06.009
Abstract: The purpose of this work is to develop a novel type of tissue engineering scaffold or drugs delivery carrier with the capability of encapsulation and controlled release drugs. In this study, Rhodamine B and Bovine Serum Albumin (BSA) were successfully incorporated into nanofibers by means of emulsion electrospinning. The morphology of composite nanofibers was studied by Scanning Electron Microscopy (SEM). The composite nanofibrous mats made from emulsion electrospinning were characterized by water contact angle measurement and X-ray diffraction. In vitro dual drugs release behaviors from composite nanofibrous mats were investigated. The results indicated that the incorporated drug and/or proteins in composite fibrous mats made from electrospinning could be control released by adjusting the processes of emulsions preparation. © 2009 Elsevier B.V. All rights reserved.
Source Title: Colloids and Surfaces B: Biointerfaces
URI: http://scholarbank.nus.edu.sg/handle/10635/59794
ISSN: 09277765
DOI: 10.1016/j.colsurfb.2009.06.009
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

80
checked on Oct 15, 2018

WEB OF SCIENCETM
Citations

47
checked on Oct 8, 2018

Page view(s)

47
checked on Oct 13, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.